Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Disease”

2,288 trials

Showing 20 of 2,288 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Large-scale testing (Phase 3)Study completedNCT00121407
What this trial is testing

Visudyne® in Occult (VIO)

Who this might be right for
Macular Degeneration
QLT Inc. 364
Not applicableStudy completedNCT01510392
What this trial is testing

CEI Van Outreach Screening Study

Who this might be right for
GlaucomaMacular DiseaseKeratoconus
Oregon Health and Science University 118
Testing effectiveness (Phase 2)Study completedNCT00940407
What this trial is testing

Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration

Who this might be right for
Nonexudative Age-related Macular Degeneration
Merry, Graham, M.D. 18
Early research (Phase 1)Study completedNCT01581411
What this trial is testing

Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
Weill Medical College of Cornell University 1
Not applicableStudy completedNCT04778436
What this trial is testing

Macula Evolution in Patients With AMD Taking Oral Food Supplementation

Who this might be right for
Age Related Macular Degeneration
Laboratoires Thea 10
Post-approval studies (Phase 4)Study completedNCT00331435
What this trial is testing

PDT Study for Exudative AMD With PCV

Who this might be right for
Age Related Macular Degeneration
Ophthalmic PDT Study Group 113
Testing effectiveness (Phase 2)Study completedNCT02462889
What this trial is testing

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration
Jeffrey S Heier 128
Not applicableStudy completedNCT03264391
What this trial is testing

Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography

Who this might be right for
Retinal VasculitisBehcet Syndrome
Assiut University 30
Post-approval studies (Phase 4)Study completedNCT02689518
What this trial is testing

EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection

Who this might be right for
Macular DegenerationWet Macular Degeneration
University of California, San Diego 50
Not applicableLooking for participantsNCT06046118
What this trial is testing

Photobiomodulation in Dry Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 180
Not applicableNot Yet RecruitingNCT07338513
What this trial is testing

User-centric Study of Patients' Receptiveness Towards the Web-based Automated Vision Impairment Gaze-tracking Analysis Systems

Who this might be right for
Age-Related Macular DegenerationWet Age-related Macular Degeneration
Tan Tock Seng Hospital 30
Not applicableStudy completedNCT01451710
What this trial is testing

The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy

Who this might be right for
IgA Nephropathy
Nanjing University School of Medicine 30
Early research (Phase 1)Study completedNCT02848313
What this trial is testing

An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Stealth BioTherapeutics Inc. 40
Not applicableStudy completedNCT04883697
What this trial is testing

Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap Technique

Who this might be right for
Macular Holes
Vienna Institute for Research in Ocular Surgery 71
Testing effectiveness (Phase 2)Study completedNCT00006202
What this trial is testing

Lutein for Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 45
Not applicableUnknownNCT01969929
What this trial is testing

Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy

Who this might be right for
Macular HoleMacular Pucker
University of Cologne 100
Not applicableNot Yet RecruitingNCT05418231
What this trial is testing

Observation of the Natural Course of Age-related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationMacular Degeneration, Dry
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 500
Not applicableLooking for participantsNCT07144137
What this trial is testing

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75
Testing effectiveness (Phase 2)Study completedNCT02401945
What this trial is testing

A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Santen Inc. 16
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation